{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:46:54Z","timestamp":1792000014831,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["20244Y0025"],"award-info":[{"award-number":["20244Y0025"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Epstein-Barr virus (EBV) -associated diseases comprise a spectrum of conditions, including infectious mononucleosis (IM) and chronic active EBV infections (CAEBV), as well as malignant lymphomas. The study aimed to compare genomic variations of Type 1 EBV across different subtypes of EBV-associated diseases to investigate the impact of EBV variants on disease progression and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 36 patients with EBV-associated diseases were enrolled. Targeted EBV genome sequencing on EBV genomic was performed with peripheral blood DNA samples (400\u00b5L) using Illumina sequencing technology. Following quality control with FastQC, Fastp, and TriTrimmomatic, 27 samples comprising 2 IM, 9 CAEBV and 16 NK\/T-cell lymphoma cases meeting the critera of minimum effective coverage\u2009&gt;\u200910 and coverage\u2009&gt;\u200980% were retained. Single nucleotide polymorphisms (SNP) annotations were generated into VCF files, and variant profiles were visualized using heatmaps. Variant rates were compared using Fisher\u2019s exact test, based on disease subtype, presence of hemophagocytic lymphohistiocystosis (HLH), and clinical outcomes. Odds ratios (ORs) were calculated using the Haldane-Anscombe correction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with the reference stain B95.8\/Raji, a total of 2182 variants were identified in 27 samples. The variants located in coding region included 523 missense variants, 1 insertion, and 2 deletion, all of which only involved single amino acid changes in the encoded proteins. Although a large number of variants were detected, no statistically significant differences were observed among the IM, CAEBV and lymphoma groups, or between patients with and without HLH. However, three variants in BFLF1 were significantly more frequent in deceased patients compared to survivors, which detailedly refers to Ile35Thr, Asp44Glu and Val246Ile [\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.0267, OR\u2009=\u200915.00, 95%CI= (0.7436,301.5)].\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Single amino acid changes in EBV proteins had no significant effect on the progression status of EBV-associated diseases, but the variants in BFLF1 were associated with an increased risk of mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41065-026-00708-4","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T14:33:25Z","timestamp":1784039605000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BFLF1 gene polymorphisms are associated with increased mortality in patients with EBV-associated diseases"],"prefix":"10.1186","volume":"163","author":[{"given":"Xurong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingluan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"4","key":"708_CR1","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/cas.13954","volume":"110","author":"T Kanda","year":"2019","unstructured":"Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019;110(4):1132\u20139. https:\/\/doi.org\/10.1111\/cas.13954.","journal-title":"Cancer Sci"},{"issue":"11","key":"708_CR2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/s41579-019-0249-7","volume":"17","author":"C M\u00fcnz","year":"2019","unstructured":"M\u00fcnz C. Latency and lytic replication in Epstein-Barr virus-associated oncogenesis. Nat Rev Microbiol. 2019;17(11):691\u2013700. https:\/\/doi.org\/10.1038\/s41579-019-0249-7.","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"708_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00428-022-03414-4","volume":"482","author":"L Quintanilla-Martinez","year":"2023","unstructured":"Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders. Virchows Arch. 2023;482(1):227\u201344. https:\/\/doi.org\/10.1007\/s00428-022-03414-4.","journal-title":"Virchows Arch"},{"issue":"14","key":"708_CR4","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1182\/blood.2025032277","volume":"147","author":"H Kimura","year":"2026","unstructured":"Kimura H, Cohen JI. Chronic active Epstein-Barr virus disease: molecular pathogenesis, evolving concepts, and emerging therapies. Blood. 2026;147(14):1562\u201373. https:\/\/doi.org\/10.1182\/blood.2025032277.","journal-title":"Blood"},{"issue":"5","key":"708_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.blre.2007.05.001","volume":"21","author":"GE Janka","year":"2007","unstructured":"Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21(5):245\u201353. https:\/\/doi.org\/10.1016\/j.blre.2007.05.001.","journal-title":"Blood Rev"},{"issue":"4","key":"708_CR6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00106-004-1210-1","volume":"53","author":"LE Walther","year":"2005","unstructured":"Walther LE, Ilgner J, Oehme A, Schmidt P, Sellhaus B, Gudziol H, Beleites E, Westhofen M. Die infekti\u00f6se Mononukleose [Infectious mononucleosis]. HNO. 2005;53(4):383\u201392. https:\/\/doi.org\/10.1007\/s00106-004-1210-1. quiz 393. German.","journal-title":"HNO"},{"issue":"5","key":"708_CR7","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12185-023-03660-5","volume":"118","author":"JI Kawada","year":"2023","unstructured":"Kawada JI, Ito Y, Ohshima K, Yamada M, Kataoka S, Muramatsu H, Sawada A, Wada T, Imadome KI, Arai A, Iwatsuki K, Ohga S, Kimura H. Committee for Guidelines for the Management of Chronic Active EBV Disease, Related Disorders (the MHLW Research Team in Japan). Updated guidelines for chronic active Epstein-Barr virus disease. Int J Hematol. 2023;118(5):568\u201376. https:\/\/doi.org\/10.1007\/s12185-023-03660-5.","journal-title":"Int J Hematol"},{"issue":"8","key":"708_CR8","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.modpat.2024.100512","volume":"37","author":"RN Miranda","year":"2024","unstructured":"Miranda RN, Amador C, Chan JKC, Guitart J, Rech KL, Medeiros LJ, Naresh KN. WHO fifth edition classification project. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues. Mod Pathol. 2024;37(8):100512. https:\/\/doi.org\/10.1016\/j.modpat.2024.100512.","journal-title":"Mod Pathol"},{"issue":"2","key":"708_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331. https:\/\/doi.org\/10.1002\/pbc.21039.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"708_CR10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.it.2025.03.007","volume":"46","author":"L Yuan","year":"2025","unstructured":"Yuan L, Zhong L, Krummenacher C, Zhao Q, Zhang X. Epstein-Barr virus-mediated immune evasion in tumor promotion. Trends Immunol. 2025;46(5):386\u2013402. https:\/\/doi.org\/10.1016\/j.it.2025.03.007.","journal-title":"Trends Immunol"},{"issue":"1","key":"708_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1146\/annurev-immunol-082323-035455","volume":"43","author":"S Latour","year":"2025","unstructured":"Latour S. Human Immune Responses to Epstein-Barr Virus Highlighted by Immunodeficiencies. Annu Rev Immunol. 2025;43(1):723\u201349. https:\/\/doi.org\/10.1146\/annurev-immunol-082323-035455.","journal-title":"Annu Rev Immunol"},{"key":"708_CR12","doi-asserted-by":"publisher","first-page":"200260","DOI":"10.1016\/j.tvr.2023.200260","volume":"15","author":"T Murata","year":"2023","unstructured":"Murata T. Tegument proteins of Epstein-Barr virus: Diverse functions, complex networks, and oncogenesis. Tumour Virus Res. 2023;15:200260. https:\/\/doi.org\/10.1016\/j.tvr.2023.200260.","journal-title":"Tumour Virus Res"},{"key":"708_CR13","doi-asserted-by":"publisher","unstructured":"Borozan I, Zapatka M, Frappier L, Ferretti V. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma. J Virol. 2018;92(2):e01239-17. doi: 10.1128\/JVI.01239-17. Erratum in: J Virol. 2018;92(10):e00330-18. https:\/\/doi.org\/10.1128\/JVI.00330-18","DOI":"10.1128\/JVI.00330-18"},{"issue":"13","key":"708_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1182\/blood.2024028055","volume":"146","author":"HT Khine","year":"2025","unstructured":"Khine HT, Sato Y, Hamada M, Umeda M, Iizuka A, Son S, Arai H, Kojima Y, Watanabe T, Naruse A, Goto K, Ohshima K, Akutsu Y, Nakaguro M, Satou A, Kataoka H, Ito Y, Sawada A, Kato S, Kawada JI, Murata T, Okuno Y, Kimura H. Association of Epstein-Barr virus genomic alterations with human pathologies. Blood. 2025;146(13):1533\u201345.","journal-title":"Blood"},{"issue":"2","key":"708_CR15","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1002\/rmv.2095","volume":"30","author":"T Murata","year":"2020","unstructured":"Murata T, Okuno Y, Sato Y, Watanabe T, Kimura H. Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes. Rev Med Virol. 2020;30(2):e2095. https:\/\/doi.org\/10.1002\/rmv.2095.","journal-title":"Rev Med Virol"},{"issue":"7","key":"708_CR16","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/s41588-019-0436-5","volume":"51","author":"M Xu","year":"2019","unstructured":"Xu M, Yao Y, Chen H, Zhang S, Cao SM, Zhang Z, Luo B, Liu Z, Li Z, Xiang T, He G, Feng QS, Chen LZ, Guo X, Jia WH, Chen MY, Zhang X, Xie SH, Peng R, Chang ET, Pedergnana V, Feng L, Bei JX, Xu RH, Zeng MS, Ye W, Adami HO, Lin X, Zhai W, Zeng YX, Liu J. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma. Nat Genet. 2019;51(7):1131\u20136. https:\/\/doi.org\/10.1038\/s41588-019-0436-5.","journal-title":"Nat Genet"},{"issue":"9","key":"708_CR17","doi-asserted-by":"publisher","first-page":"e0222519","DOI":"10.1371\/journal.pone.0222519","volume":"14","author":"A Sugimoto","year":"2019","unstructured":"Sugimoto A, Yamashita Y, Kanda T, Murata T, Tsurumi T. Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments. PLoS ONE. 2019;14(9):e0222519. https:\/\/doi.org\/10.1371\/journal.pone.0222519.","journal-title":"PLoS ONE"},{"issue":"4","key":"708_CR18","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1128\/JVI.02533-12","volume":"87","author":"S Pavlova","year":"2013","unstructured":"Pavlova S, Feederle R, G\u00e4rtner K, Fuchs W, Granzow H, Delecluse HJ. An Epstein-Barr virus mutant produces immunogenic defective particles devoid of viral DNA. J Virol. 2013;87(4):2011\u201322. https:\/\/doi.org\/10.1128\/JVI.02533-12.","journal-title":"J Virol"},{"issue":"8","key":"708_CR19","doi-asserted-by":"publisher","first-page":"e037505","DOI":"10.1136\/bmjopen-2020-037505","volume":"10","author":"G Khan","year":"2020","unstructured":"Khan G, Fitzmaurice C, Naghavi M, Ahmed LA. Global and regional incidence, mortality and disability-adjusted life-years for Epstein-Barr virus-attributable malignancies, 1990\u20132017. BMJ Open. 2020;10(8):e037505. https:\/\/doi.org\/10.1136\/bmjopen-2020-037505.","journal-title":"BMJ Open"},{"issue":"10","key":"708_CR20","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1128\/JVI.03614-14","volume":"89","author":"AL Palser","year":"2015","unstructured":"Palser AL, Grayson NE, White RE, Corton C, Correia S, Ba Abdullah MM, Watson SJ, Cotten M, Arrand JR, Murray PG, Allday MJ, Rickinson AB, Young LS, Farrell PJ, Kellam P. Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection. J Virol. 2015;89(10):5222\u201337. https:\/\/doi.org\/10.1128\/JVI.03614-14.","journal-title":"J Virol"},{"issue":"9","key":"708_CR21","doi-asserted-by":"publisher","first-page":"e905","DOI":"10.1634\/theoncologist.2017-0588","volume":"24","author":"N Lin","year":"2019","unstructured":"Lin N, Ku W, Song Y, Zhu J, Lu Z. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK\/T-Cell Lymphoma, Nasal Type. Oncologist. 2019;24(9):e905\u201313. https:\/\/doi.org\/10.1634\/theoncologist.2017-0588.","journal-title":"Oncologist"},{"key":"708_CR22","unstructured":"Li XR, Wu J, Yu SL, Zhou Z, Zhang WH, Shao LY, Jiang N, Yang QL. The impact of Epstein-Barr Virus genomic variations on clinical subtypes and prognosis in EBV-associated diseases. Url: https:\/\/data.4tu.nl\/private_datasets\/Mcui8_q05h_qSV71balx0le6Nl_RGPdGh7vTVfB9G_c"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00708-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00708-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-026-00708-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:02:02Z","timestamp":1791997322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-026-00708-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["708"],"URL":"https:\/\/doi.org\/10.1186\/s41065-026-00708-4","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"5 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving human participants were performed in accordance with the ethical standards of the Declaration of Helsinki. This study was reviewed and approved by the Ethics Committee of Huashan Hospital (KY2020-1122).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"112"}}